Service de chirurgie orthopédique, hôpital André-Mignot, 177, rue de Versailles, 78150 Le Chesnay, France.
Service de chirurgie orthopédique, hôpital André-Mignot, 177, rue de Versailles, 78150 Le Chesnay, France.
Orthop Traumatol Surg Res. 2020 May;106(3):475-479. doi: 10.1016/j.otsr.2019.12.014. Epub 2020 Apr 3.
Collagen scaffolds are a good surgical option for covering large focal osteochondral defects in the knee. In the recent literature there is a wide range of patient profiles and chondral defect treatments (chondral and osteochondral defects, associated procedures, etc.). The aim of the present study was to evaluate clinical and imaging outcomes with collagen scaffolds and to assess any correlation between medium-term clinical outcome and MRI features. The hypothesis was that there is no correlation between clinical outcome and MRI after 2 years postoperatively.
A single-center retrospective observational study included all patients receiving a MaioRegen® scaffold for large painful focal osteochondral defect of the femoral condyle. There were 17 patients, with a mean age of 28±9 years. Defect locations comprised 12 medial femoral condyles, 4 lateral femoral condyles and 1 lateral tibial plateau. Mean defect area was 4.5±1.4cm. All patients were evaluated clinically and on KOOS and objective and subjective IKDC scales, with MRI at last follow-up.
At a mean follow-up of 46±17 months, mean subjective IKDC was 67.8±23; KOOS scores were: symptoms, 78±22; pain, 78±23; function, 85±20; sports, 66±27; and activities of daily living, 59±25. MRI MOCART score revealed incomplete scaffold healing in 21.4% of cases, with variable signal intensity within regenerated tissue. Functional scores did not correlate with reconstruction aspect on MRI.
DISCUSSION/CONCLUSION: 3D collagen scaffolds yield good medium-term clinical outcomes in large osteochondral defects of the knee. There is, however, a discrepancy between MRI features of the recipient site and objective and subjective clinical scores. These scaffolds may be a good option for treating large focal osteochondral defects in knees of young patients, but MRI does not provide satisfactory medium-term assessment.
胶原蛋白支架是一种很好的手术选择,可用于覆盖膝关节内的大灶性骨软骨缺损。在最近的文献中,患者的情况和软骨缺损的治疗方法(软骨和骨软骨缺损、相关手术等)范围广泛。本研究的目的是评估胶原蛋白支架的临床和影像学结果,并评估中期临床结果与 MRI 特征之间的任何相关性。假设是在术后 2 年,临床结果与 MRI 之间没有相关性。
一项单中心回顾性观察性研究纳入了所有接受 MaioRegen®支架治疗股骨髁大而疼痛性局灶性骨软骨缺损的患者。共有 17 例患者,平均年龄 28±9 岁。缺陷部位包括 12 个内侧股骨髁、4 个外侧股骨髁和 1 个外侧胫骨平台。平均缺损面积为 4.5±1.4cm。所有患者均接受临床评估、KOOS 评分以及客观和主观 IKDC 评分,并在最后一次随访时进行 MRI 检查。
平均随访 46±17 个月时,平均主观 IKDC 为 67.8±23;KOOS 评分分别为:症状,78±22;疼痛,78±23;功能,85±20;运动,66±27;和日常生活活动,59±25。MRI MOCART 评分显示 21.4%的病例支架愈合不完全,再生组织内信号强度不同。功能评分与 MRI 上的重建情况无关。
讨论/结论:3D 胶原蛋白支架可使膝关节大骨软骨缺损获得良好的中期临床效果。然而,在接受部位的 MRI 特征与客观和主观临床评分之间存在差异。这些支架可能是治疗年轻患者膝关节大灶性骨软骨缺损的一种较好的选择,但 MRI 不能提供令人满意的中期评估。